Chr Hansen Holding A/S
CSE:CHR

Watchlist Manager
Chr Hansen Holding A/S Logo
Chr Hansen Holding A/S
CSE:CHR
Watchlist
Price: 549.6 DKK -0.61% Market Closed
Market Cap: 72.3B DKK
Have any thoughts about
Chr Hansen Holding A/S?
Write Note

Chr Hansen Holding A/S
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Chr Hansen Holding A/S
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Chr Hansen Holding A/S
CSE:CHR
Total Equity
€1.9B
CAGR 3-Years
29%
CAGR 5-Years
20%
CAGR 10-Years
11%
Novozymes A/S
CSE:NZYM B
Total Equity
kr14B
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
N/A
P
Photocat A/S
STO:PCAT
Total Equity
kr12.7m
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

Chr Hansen Holding A/S
Glance View

Market Cap
72.3B DKK
Industry
Chemicals

Chr Hansen Holding A/S is a global leader in the natural ingredients market, specializing in the production of cultures, enzymes, and probiotics for various industries, including food, beverages, pharmaceuticals, and dietary supplements. Founded in 1874 and headquartered in Denmark, the company has established a solid reputation for its commitment to sustainability and innovation. With a focus on harnessing the power of nature, Chr Hansen's products enhance the quality, safety, and shelf life of food while promoting health through natural solutions. This strategic positioning not only supports a more sustainable food system but also aligns with the growing consumer demand for clean-label products and healthier choices. For investors, Chr Hansen presents a compelling opportunity, driven by its strong market presence and a portfolio of patented technologies that set it apart from competitors. The company benefits from a diverse customer base, serving major global brands as well as local businesses, and has demonstrated consistent revenue growth through strategic acquisitions and partnerships. With its investments in research and development, Chr Hansen is well-poised to capitalize on emerging trends in health and nutrition, making it a potential long-term investment for those seeking exposure to the burgeoning field of natural ingredients. As consumers become more aware of the health benefits of probiotics and natural food additives, Chr Hansen's unwavering focus on sustainability and innovation makes it a standout player in a competitive market.

CHR Intrinsic Value
382.12 DKK
Overvaluation 30%
Intrinsic Value
Price

See Also

What is Chr Hansen Holding A/S's Total Equity?
Total Equity
1.9B EUR

Based on the financial report for Aug 31, 2023, Chr Hansen Holding A/S's Total Equity amounts to 1.9B EUR.

What is Chr Hansen Holding A/S's Total Equity growth rate?
Total Equity CAGR 10Y
11%

Over the last year, the Total Equity growth was 4%. The average annual Total Equity growth rates for Chr Hansen Holding A/S have been 29% over the past three years , 20% over the past five years , and 11% over the past ten years .

Back to Top